CILP Antikörper (Internal Region)
-
- Target Alle CILP Antikörper anzeigen
- CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Ratte
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CILP Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- CILP
- Sequenz
- NYRRTDHEDP RVK
- Kreuzreaktivität
- Hund, Human, Maus, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence C-NYRRTDHEDPRVK, from the internal region of the protein sequence according to NP_003604.2.
- Isotyp
- IgG
- Top Product
- Discover our top product CILP Primärantikörper
-
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 603-846) antibody
CILP Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 604-864) antibodyCILP Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 1051-1184) antibodyCILP Reaktivität: Human, Ratte WB, ELISA, FACS, ICC, IF (cc), IF (p), IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 129-226) antibodyCILP Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 129-226) antibodyCILP Reaktivität: Human ELISA Wirt: Maus Monoclonal 2C5 unconjugated
anti-Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP) (AA 129-226) antibodyCILP Reaktivität: Human ELISA Wirt: Maus Monoclonal 2D10 unconjugated
-
- Applikationshinweise
-
Western Blot: Approx 150 kDa band observed in rat spinal cord lysates (calculated MW of 133 kDa according to human NP_003604.2 and of 132 kDa according to Rat NP_001101631.1). Recommended concentration: 0.1-0.3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:128000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- CILP (Cartilage Intermediate Layer Protein, Nucleotide Pyrophosphohydrolase (CILP))
- Andere Bezeichnung
- CILP (CILP Produkte)
- Hintergrund
- CILP, cartilage intermediate layer protein, nucleotide pyrophosphohydrolase , HGNC:1980, HsT18872 , cartilage intermediate layer protein
- Gen-ID
- 8483, 214425, 315761
- NCBI Accession
- NP_003604
-
